Exploring Opportunities to Advance Companion Diagnostic Co-Development in an Evolving Global Regulatory Environment
Time: 10:20 am
day: Day One
Details:
- Brief overview of current regulatory landscape for companion diagnostics
- Regulatory concepts and considerations that should be considered for biomarker testing in global therapeutic clinical trials
- Potential strategies for addressing upcoming regulatory challenges in companion diagnostic co-development
